glp 1 for non obese GLP-1 weight loss drugs leave users low on key nutrients, study finds GLP-1 agonists and changes in

Human data (from a meta-analysis of 894 participants) show fenugreek supplementation (0.5 g to 10 g daily over 4 weeks to 6 months) reduces fasting glucose, post-meal glucose, and HbA1c

At the core of GLP-1 Formula is dihydroberberine (DHB), a highly bioavailable form of berberine known for its ability to support healthy blood sugar metabolism and insulin sensitivity

Explore BCBS of Illinois coverage for Semaglutide (Wegovy), reasons for denial, tips for approval, costs without insurance, and answers to common questions.

Understand causes, relief and side effects of this weight loss treatment

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

Medicare GLP-1 Bridge program offers $50 copayment for weight loss drugs to eligible Medicare beneficiaries.